$1.10
N/A
In chiusura: Nov 19, 4:00 PM EST

ProQR Therapeutics (PRQR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.10 | $-0.11 | 6.36 % |
| Q2 | Aug 13, 2026 | $-0.09 | $-0.14 | 35.7 % |
| Q1 | May 12, 2026 | $-0.15 | $-0.15 | 0.00 % |
| Q4 | Mar 12, 2026 | $-0.09 | $-0.08 | -12.5 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $5.93M | $5.35M | 10.9 % |
| Q2 | Aug 13, 2026 | $10.18M | $5.56M | 83.2 % |
| Q1 | May 12, 2026 | $2.38M | $5.53M | -56.9 % |
| Q4 | Mar 12, 2026 | $5.46M | $8.55M | -36.2 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.14 | $-0.15 | $-0.08 |
| Actual | $-0.10 | $-0.09 | $-0.15 | $-0.09 |
| Surprise | +6.36% | +35.7% | 0.00% | -12.5% |
| Revenue | ||||
| Estimate | $5.3M | $5.6M | $5.5M | $8.6M |
| Actual | $5.9M | $10.2M | $2.4M | $5.5M |
| Surprise | +10.9% | +83.2% | -56.9% | -36.2% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.13 | $-0.13 | $-0.13 |
| Revenue | ||||
| Consensus | $4.7M | $5.2M | — | — |